For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 140,325 | |||
| General and administrative | 38,881 | |||
| Total operating expenses | 179,206 | |||
| Loss from operations | -179,206 | |||
| Interest income | 9,904 | |||
| Interest expense | -203 | |||
| Change in fair value of derivative liabilities | -6,050 | |||
| Other income, net | 824 | |||
| Total other income, net | 4,881 | |||
| Net loss | -174,325 | |||
| Basic EPS | -1.99 | |||
| Diluted EPS | -1.99 | |||
| Basic Average Shares | 87,504,631 | |||
| Diluted Average Shares | 87,504,631 | |||
Solid Biosciences Inc. (SLDB)
Solid Biosciences Inc. (SLDB)